SKA1 overexpression is associated with the�prognosis of esophageal squamous cell carcinoma and regulates cell proliferation and migration-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

SKA1 overexpression is associated with the�prognosis of esophageal squamous cell carcinoma and regulates cell proliferation and migration

Published:2019-09-17 Issue: Volume: Page:
ISSN:1107-3756
Container-title:International Journal of Molecular Medicine
language:
Short-container-title:Int J Mol Med

Author:

Hu Dongxin¹,Li Zhen²,Li Xiao²,Fu Honghao¹,Zhang Mingyan²

Affiliation:

1. Department of Thoracic Surgery, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, Shandong 250021, P.R. China

2. Department of Gastroenterology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, Shandong 250021, P.R. China

Publisher

Spandidos Publications

Subject

Genetics,General Medicine

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. LINC00963 Promotes Cisplatin Resistance in Esophageal Squamous Cell Carcinoma by Interacting with miR-10a to Upregulate SKA1 Expression;Applied Biochemistry and Biotechnology;2024-03-20

2. Pancancer analysis of SKA1 mutation and its association with the diagnosis and prognosis of human cancers;Genomics;2023-03

3. SKA1/2/3 is a biomarker of poor prognosis in human hepatocellular carcinoma;Frontiers in Oncology;2022-11-10

4. ETV5 overexpression promotes progression of esophageal squamous cell carcinoma by upregulating SKA1 and TRPV2;International Journal of Medical Sciences;2022

5. Transcript levels of spindle and kinetochore-associated complex 1/3 as prognostic biomarkers correlated with immune infiltrates in hepatocellular carcinoma;Scientific Reports;2021-05-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3